NovaTears® Eye Drops Observational Study

Novaliq

Status: Completed

Conditions: Dry Eye Disease

Treatments: Device: NovaTears® Eye Drops

Study type: Observational

Funder types: Industry

Identifiers

NCT02111928

NT-001

Details and patient eligibility

About

This observational pilot-study is intended to collect outcome data from a cohort of 30 patients suffering from hyper-evaporative dry eye disease who are treated with the medical device NovaTears® eye drops for a duration of 5 to 7 weeks.

Enrollment: 30 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• According to NovaTears® instruction for use
• ≥ 18 years
• Patients with mild to moderate disease and hyper-evaporative dry eye disease applying eye lid hygiene for at least 14 days
• Ability and willingness to provide written Informed Consent
• Ability and willingness to participate in all examinations
• Willingness and ability to return for follow up visit

Exclusion criteria

• Patients with hypersensitivity to any of the components of NovaTears®
• Patients with contact lenses, pregnancies, or who are breast feeding
• Patients with non evaporate dry eye disease
• Patients taking lipid containing eye drops or requiring pharmacologic treatment of dry eye disease

Trial design

30 participants in 1 patient group

NovaTears®

Treatment:

Device: NovaTears® Eye Drops